- Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
null null et al, 2024, Cochrane Database of Systematic Reviews CrossRef - COMPARISON OF EFFICACY IN RENOPROTECTION BETWEEN AZILSARTAN AND ENALAPRIL: A RANDOMIZED CONTROLLED TRIAL
Ployrawee Thanaprirax et al, 2023, Journal of Southeast Asian Medical Research CrossRef - Telmisartan versus EnalapRil In heart failure with redUced ejection fraction patients with Moderately impaired kidney Functions; randomized controlled trial: “TRIUMF trial”
Ahmad Samir et al, 2023, The Egyptian Heart Journal CrossRef - Angiotensin Type 1 Receptor Blockers in Heart Failure
Khuraijam Dhanachandra Singh et al, 2020, Current Drug Targets CrossRef